Canadian Pharmaceuticals & Biotech Most Popular Stocks

Curaleaf Holdings

Market Cap: CA$2.7b

Produces and distributes cannabis products in the United States and internationally.

Green Thumb Industries

Market Cap: CA$2.6b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Trulieve Cannabis

Market Cap: CA$2.0b

Operates as a cannabis retailer.

Cronos Group

Market Cap: CA$1.4b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Bright Minds Biosciences

Market Cap: CA$932.5m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Vireo Growth

Market Cap: CA$885.9m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Cresco Labs

Market Cap: CA$781.4m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

NervGen Pharma

Market Cap: CA$643.1m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

Verano Holdings

Market Cap: CA$628.4m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Canopy Growth

Market Cap: CA$609.1m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

Eupraxia Pharmaceuticals

Market Cap: CA$602.2m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Knight Therapeutics

Market Cap: CA$591.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Spectral Medical

Market Cap: CA$409.6m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

TerrAscend

Market Cap: CA$404.5m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Cipher Pharmaceuticals

Market Cap: CA$384.2m

Operates as a specialty pharmaceutical company in Canada.

Aurora Cannabis

Market Cap: CA$334.6m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

High Tide

Market Cap: CA$324.1m

Engages in the cannabis retail business in Canada.

Organigram Global

Market Cap: CA$321.3m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Auxly Cannabis Group

Market Cap: CA$198.2m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Helix BioPharma

Market Cap: CA$183.3m

A clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.

Grown Rogue International

Market Cap: CA$154.8m

A craft cannabis company, focuses on premium flower and flower-derived products.

Satellos Bioscience

Market Cap: CA$154.0m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

HLS Therapeutics

Market Cap: CA$150.4m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

BioSyent

Market Cap: CA$144.9m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Cardiol Therapeutics

Market Cap: CA$138.4m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Atlas Energy

Market Cap: CA$103.9m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

Medexus Pharmaceuticals

Market Cap: CA$97.4m

Operates as a pharmaceutical company in Canada and the United States.

Planet 13 Holdings

Market Cap: CA$94.4m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

ME Therapeutics Holdings

Market Cap: CA$90.1m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

Charlotte's Web Holdings

Market Cap: CA$84.5m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

MTL Cannabis

Market Cap: CA$83.0m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

Medicenna Therapeutics

Market Cap: CA$78.4m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

BioNxt Solutions

Market Cap: CA$75.9m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

Onco-Innovations

Market Cap: CA$73.0m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

Vext Science

Market Cap: CA$67.8m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

LIR Life Sciences

Market Cap: CA$63.0m

Operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders.